We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$735M
AUM Growth
-$32.3M
Cap. Flow
-$7.57M
Cap. Flow %
-1.03%
Top 10 Hldgs %
32.72%
Holding
167
New
11
Increased
20
Reduced
93
Closed
7

Top Buys

Rank Stock Value
1
ITRI icon
Itron
ITRI
+$3.82M
2
MRK icon
Merck
MRK
+$3.66M
3
UCTT
Ultra Clean Holdings
UCTT
+$3.23M
4
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$2.47M
5
COHR icon
Coherent
COHR
+$2.31M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$14.7M
2
GSK icon
GSK
GSK
+$5.1M
3
ALB icon
Albemarle
ALB
+$4.22M
4
PGJ icon
Invesco Golden Dragon China ETF
PGJ
+$2.39M
5
XRX icon
Xerox
XRX
+$1.4M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 21.31%
3 Industrials 18.46%
4 Utilities 17.61%
5 Communication Services 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$36.3M 4.94%
385,767
-7,528
-2% -$751K
PFE icon
2
Pfizer
PFE
$159B
$27.7M 3.76%
643,450
-10,163
-2% -$450K
OGE icon
3
OGE Energy
OGE
$9.45B
$25.8M 3.51%
783,244
-1,911
-0.2% -$66K
VZ icon
4
Verizon
VZ
$208B
$23.3M 3.17%
431,390
+7,884
+2% +$436K
GLW icon
5
Corning
GLW
$128B
$23.2M 3.16%
635,820
+25,622
+4% +$1.02M
BMY icon
6
Bristol-Myers Squibb
BMY
$136B
$23.1M 3.14%
390,047
-783
-0.2% -$51.6K
CSCO icon
7
Cisco
CSCO
$433B
$21.4M 2.92%
394,017
-4,050
-1% -$227K
IBM icon
8
IBM
IBM
$222B
$20.9M 2.84%
157,235
-4,331
-3% -$579K
INTC icon
9
Intel
INTC
$473B
$19.7M 2.68%
370,186
-6,680
-2% -$362K
T icon
10
AT&T
T
$178B
$19.1M 2.6%
937,732
-13,815
-1% -$290K
AQN icon
11
Algonquin Power & Utilities
AQN
$4.36B
$16.7M 2.27%
1,137,253
+14,884
+1% +$230K
BCE icon
12
BCE
BCE
$21.9B
$16.5M 2.24%
329,039
-7,276
-2% -$368K
MDU icon
13
MDU Resources
MDU
$4.16B
$15.7M 2.13%
1,388,124
-11,485
-0.8% -$138K
GSK icon
14
GSK
GSK
$102B
$15.2M 2.07%
318,126
-101,452
-24% -$5.1M
FLS icon
15
Flowserve
FLS
$10.2B
$14.3M 1.95%
413,079
+21,850
+6% +$855K
NVS icon
16
Novartis
NVS
$292B
$14.3M 1.95%
174,954
-180
-0.1% -$16.2K
XOM icon
17
ExxonMobil
XOM
$644B
$13.8M 1.88%
234,783
-4,400
-2% -$251K
AGX icon
18
Argan
AGX
$5.86B
$13.8M 1.87%
315,036
-24,797
-7% -$1.12M
ELAN icon
19
Elanco Animal Health
ELAN
$12B
$13M 1.76%
406,265
-17,460
-4% -$586K
HE icon
20
Hawaiian Electric Industries
HE
$1.97B
$12.9M 1.75%
315,282
-1,158
-0.4% -$49.7K
MMM icon
21
3M
MMM
$89.9B
$12.8M 1.75%
87,581
-657
-0.7% -$106K
XRAY icon
22
Dentsply Sirona
XRAY
$2.22B
$12.6M 1.71%
216,533
-1,609
-0.7% -$99.2K
LGTY
23
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$12.4M 1.68%
520,373
-15,150
-3% -$349K
D icon
24
Dominion Energy
D
$57.7B
$10.9M 1.49%
149,586
-1,258
-0.8% -$95.9K
MSFT icon
25
Microsoft
MSFT
$3.81T
$10.7M 1.46%
38,065
-555
-1% -$161K
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, John G. Ullman & Associates held 167 positions worth $735M, down 4.2% from $768M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2021 filing shows 11 new, 20 increased, 93 reduced and 7 closed positions. Its largest new stake was Ultra Clean Holdings: 68,404 shares worth $2.91M. The largest sale was Johnson & Johnson, an estimated $14.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q3 2021 buy was Ultra Clean Holdings: 68,404 shares worth $2.91M.
  • John G. Ullman & Associates added most to Itron in Q3 2021, an estimated $3.82M increase.
  • John G. Ullman & Associates's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $14.7M.
  • John G. Ullman & Associates fully exited Albemarle in Q3 2021, selling an estimated $4.22M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $735M portfolio in Q3 2021.
  • John G. Ullman & Associates opened 11 new positions and closed 7 in Q3 2021.
  • John G. Ullman & Associates's portfolio value fell 4.2% quarter-over-quarter to $735M.

Based on John G. Ullman & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.